Cellular Origins of EGFR‐Driven Lung Cancer Cells Determine Sensitivity to Therapy
Abstract Targeting the epidermal growth factor receptor (EGFR) with tyrosine kinase inhibitors (TKIs) is one of the major precision medicine treatment options for lung adenocarcinoma. Due to common development of drug resistance to first‐ and second‐generation TKIs, third‐generation inhibitors, incl...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Wiley
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/1d70799b294842b6a8cf3f7bd6a3471b |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|